Mold-Tek Packaging Ltd

Meeting Details

• Board meeting on August 26, 2026; time and venue not disclosed.

Key Agenda Items

• Issuance of fully paid Bonus Equity Shares to existing shareholders.
• Increase in Authorized Share Capital, subject to shareholder approval.
• Recommend final dividend for FY 2025-26, if any.
• Fix AGM date, time, venue, and approve the AGM Notice.
• Set Cut-off/Record date for final dividend and AGM e-voting.

Other Notes

• No other material notes disclosed in this filing.

Meeting Details

• Date and time: August 10, 2026, 11:00 AM–03:00 PM IST.
• Meeting type and mode: Group meeting, physical in Mumbai.
• Organizer: Nirmal Bang Institutional Equities.

Participants

• Company officials will participate.

Purpose

• Participation in the Semi-Annual Investor Conference organized by Nirmal Bang.

Meeting Details

• Date and time: August 10, 2026, 11:00 AM–03:00 PM IST.
• Type and mode: Group investor meeting; physical venue in Mumbai.
• Organizer: Nirmal Bang Institutional Equities; Semi-Annual Investor Conference.
• Purpose: Analyst and institutional investor interaction.
• Key participants: Company officials (management) attending.

Conference call details

• Audio recording of the July 27, 2026 investor conference call at 4:30 PM IST is uploaded.

Meeting Details

• Date and time: 27 July 2026 at 4:30 PM IST.
• Type/Mode: Conference call for investors, virtual.
• Organiser: Mold-Tek Packaging Limited.

Participants

• Key company participant: Chairman and Managing Director.

Purpose

• Discuss Q1 FY27 results with investors.

Additional Notes

• Audio recording of the conference call uploaded on the company website.

Business Overview

• Leading Indian rigid plastic packaging player with IML and backward integration.
• 10 manufacturing units nationwide; injection molding capacity ~66,900 TPA.
• Key customers include Asian Paints, Castrol, Shell, Mondelez, HUL.
• R&D focus on metallized IML and AI-enabled automation.
• Backwards integration supports cost efficiency and margin resilience.

Operational Highlights

• Five plants consolidated into two locations to boost EBITDA.
• Product mix expanded into Panipat, Cheyyar, Daman and Satara.
• Pharma segment momentum with 40% quarterly growth.
• New metallized IML and shapes for FMCG.
• Automation via camera inspection and AI; supply disruption resilient.
• Volume up 6.25% to 12,089 MT.
• Delivery on time despite supply shocks.

Financial Performance

• Revenue Rs 300.45 cr, up 24.9% YoY.
• EBITDA Rs 56.43 cr, up 19.11%.
• PAT Rs 25.57 cr, up 14.19%; PAT margin 8.51%.
• EPS Rs 7.70; Cash PAT Rs 42.12 cr; 14.02% cash margin.
• Volume 12,089 MT; +6.25% YoY.
• PBT Rs 34.17 cr; PBT margin 11.37%.
• Tax expense Rs 8.60 cr.

Strategic Priorities & Outlook

• Strategic consolidation and expansion to drive EBITDA growth.
• Expand product mix and geographic reach in Pharma and FMCG.
• Invest in R&D, automation, and faster innovation cycles.
• Forecast idle capacities proactively; maintain low MOQ, sequencing.
• Future-ready packaging strategy to navigate volatility.

Risks & Mitigation

• Supply chain shocks can impact costs; mitigated by backward integration.
• Pricing and raw materials volatility addressed by diversified suppliers.
• Delivery risks reduced via on-time delivery and agile production sequencing.

Governance & Leadership

• Chairman & MD: J. Lakshmana Rao.

Meeting Details

• Q1 FY27 investor presentation for quarter ended June 30, 2026 disclosed in filing dated July 27, 2026.

Participants

• Key company participants: Chairman and Managing Director.

Purpose

• Purpose: discuss Q1 FY27 results with investors.

Additional Notes

• Presentation materials will be uploaded on the company website.

Financial Highlights

• Net Sales rose 26.32% YoY to Rs 300.45 crore in Q1 FY27.
• EBITDA up 17.31% to Rs 56.43 crore; EBITDA per kg Rs 46.68 (historic high).
• Net Profit (PAT) rose 23.89% to Rs 25.57 crore.
• PBT increased 13.86% to Rs 34.17 crore.
• Sales volume grew 5.82% to 12,089 MT.

Operational & Capacity

• Consolidated Hyderabad units into two major sites (Annaram, Sultanpur) to 75% capacity utilization.
• Additional molding machines commissioned for Pharma; eight new injection moulding machines at Sultanpur/Hyderabad.

Segment Trends

• Pharma packaging volumes up 38.75% YoY.
• Food & FMCG volumes up 26.20%.
• Paints volumes up 10.82%.
• Lube packs demand declined due to input issues from Iran war.

Outlook & Capex

• Plans to enter Ophthalmic-Packs and other medical devices.
• Exploring electronics and semiconductor packaging opportunities.
• Printing/logistics improvements supporting cost efficiencies.
• Management expects continued demand and profitability growth.